Bridge the gap between consumer wearables and clinical-grade monitoring with a platform built for trust, accuracy, and compliance.

The wearable health market is growing rapidly, but companies entering this space face a unique intersection of technical, regulatory, and clinical challenges that consumer electronics experience alone cannot address. Continuous vital sign monitoring, including heart rate, SpO2, skin temperature, and ECG, demands signal processing pipelines that maintain clinical-grade accuracy despite motion artifacts, varying skin tones, and environmental interference. Data from wearable devices is classified as protected health information (PHI) under HIPAA and equivalent regulations globally, requiring end-to-end encryption, granular access controls, and auditable data lineage that most IoT platforms were never designed to provide. Integration with electronic health records (EHR) systems like Epic and Cerner requires HL7 FHIR compliance and careful mapping of wearable telemetry to clinical data models. Additionally, any device or algorithm making health-related claims must navigate FDA 510(k) or De Novo classification pathways, demanding rigorous documentation, validation protocols, and post-market surveillance infrastructure.
MicrocosmWorks can deliver a purpose-built platform for wearable health devices that handles the full data journey from skin-level sensor to clinician dashboard while maintaining regulatory compliance at every layer. The platform's signal processing engine applies clinically validated algorithms for motion artifact removal, baseline wander correction, and beat-to-beat analysis, ensuring measurement accuracy that withstands FDA scrutiny. A HIPAA-compliant data pipeline encrypts telemetry at the device, in transit, and at rest, with role-based access control separating patient, clinician, researcher, and administrator views. Real-time anomaly detection algorithms flag concerning vital sign patterns, such as atrial fibrillation episodes, oxygen desaturation trends, or abnormal heart rate variability, and route alerts to the appropriate care team through configurable escalation pathways. Bidirectional EHR integration via FHIR APIs ensures that wearable data flows seamlessly into existing clinical workflows.
The platform follows a security-first architecture with four isolated domains: device, ingestion, analytics, and presentation. Each domain enforces its own authentication boundary, and data flows between domains through encrypted message queues with full audit logging. The device domain manages firmware, BLE communication, and on-device preprocessing. The ingestion domain handles PHI reception and de-identification. The analytics domain runs ML inference on de-identified data. The presentation domain renders patient and clinician interfaces with re-identified data accessible only to authorized roles.
| Layer | Technologies |
|---|---|
| Backend | Python (FastAPI), Go, Apache Kafka, gRPC |
| AI / ML | PyTorch, ONNX Runtime, SciPy (signal processing), BioSPPy, HeartPy |
| Frontend | React (clinician dashboard), React Native (patient app), D3.js, Storybook |
| Database | PostgreSQL (HIPAA-configured), Apache Cassandra, Amazon S3 (encrypted), Redis |
| Infrastructure | AWS GovCloud, EKS, AWS KMS, HashiCorp Vault, Terraform, SOC 2 audit tooling |
The platform is built over 14-16 weeks across four phases. Weeks 1-3 define clinical accuracy requirements, map regulatory pathways (FDA 510(k)/De Novo), and design the security-first four-domain architecture with isolated device, ingestion, analytics, and presentation boundaries on AWS GovCloud. Weeks 4-8 build the clinical signal processing pipeline with motion artifact removal and R-peak detection, implement the HIPAA compliance engine with AES-256 encryption and audit trail generation, and establish the FHIR R4-compliant EHR integration gateway for Epic and Cerner. Weeks 9-12 develop the streaming anomaly detection models for arrhythmia and oxygen desaturation, build the clinician dashboard and patient companion app with role-based PHI access controls, and implement the configurable alert escalation pathways. Weeks 13-16 conduct clinical validation studies against reference devices, prepare FDA submission documentation packages, perform penetration testing and SOC 2 audit readiness assessment, and deliver the platform with clinical operations training.
| Metric | Improvement | Detail |
|---|---|---|
| Arrhythmia Detection Sensitivity | 95%+ | Clinically validated algorithms detect AFib episodes with sensitivity comparable to Holter monitors |
| Time to Clinical Alert | <30 seconds | Streaming anomaly detection processes incoming vitals and escalates to care teams in near real time |
| EHR Documentation Time | -60% | Automated FHIR-based data flow eliminates manual transcription of wearable readings into clinical records |
| Patient Engagement | +40% | Personalized health insights and goal tracking in the companion app increase daily active usage |
| Regulatory Approval Timeline | -30% | Pre-built compliance documentation templates and validation frameworks accelerate FDA submission preparation |
Discover more implementation blueprints for your next project

Grow more with less using precision agriculture that turns soil, weather, and crop data into actionable field intelligence.

Cut energy waste by up to 35% with IoT-driven HVAC, lighting, and occupancy optimization across your entire portfolio.

Track, optimize, and protect every vehicle in real time with sub-second location accuracy and AI-driven route intelligence.
MicrocosmWorks supports continuous monitoring of heart rate, HRV, SpO2, skin temperature, electrodermal activity, sleep stages, activity levels, and with appropriate sensors, blood pressure trends and ECG waveforms. Consumer wearable accuracy typically reaches within 2-5% of clinical devices for heart rate and SpO2, sufficient for wellness monitoring and trend detection though not for clinical diagnosis.
MicrocosmWorks architects the platform with FDA De Novo or 510(k) submission requirements in mind, including clinical validation data collection frameworks, software as a medical device (SaMD) documentation, and quality management system integrations. The system maintains detailed design history files, risk analysis records, and software validation artifacts required for regulatory submissions.
MicrocosmWorks implements aggressive power management strategies including adaptive sampling rates based on activity state, edge processing to minimize Bluetooth radio active time, batch data synchronization during charging, and hardware-level sleep states that reduce idle current below 10 microamps. These techniques typically achieve 5-10 day battery life depending on sensor configuration and display usage.
The MicrocosmWorks blueprint implements end-to-end encryption from the wearable device through the mobile app to the cloud backend, with health data encrypted at rest using AES-256 and user-controlled data sharing permissions. The platform is designed for HIPAA, GDPR, and PIPEDA compliance with configurable data residency, retention policies, and de-identification capabilities for research data sharing.
Yes, MicrocosmWorks builds multi-tenant administration capabilities where enterprise customers (employers, insurers, wellness providers) manage their own member populations, view anonymized aggregate health trends, and configure program-specific engagement features. At development rates of $20-$40/hr, the B2B2C administration layer typically adds 6-8 weeks to the platform development timeline.
Contact us to discuss how we can build this solution for your business with our expert team.
Get In Touch